Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.34 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12900126 | 0.94 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2TDP1TP53CYP3A4 | |
| SCHEMBL21769282 | 0.93 | ALDH1A1 (0.45) | ALDH1A1SMN1; SMN2TDP1TP53CYP3A4 | |
| SCHEMBL9952240 | 0.91 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2TDP1TP53CYP3A4 | |
| SCHEMBL25797198 | 0.88 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2TDP1TP53CYP3A4 | |
| SCHEMBL10773349 | 0.87 | ALDH1A1 (0.41) | ALDH1A1SMN1; SMN2TDP1TP53CYP3A4 | |
| SCHEMBL12026823 | 0.84 | ALDH1A1 (0.44) | ALDH1A1SMN1; SMN2TDP1TP53CYP3A4 | |
| SCHEMBL16543533 | 0.83 | CA1 (0.35) | ALDH1A1SMN1; SMN2TDP1TP53CYP3A4 | |
| SCHEMBL16543536 | 0.82 | ALDH1A1 (0.36) | ALDH1A1SMN1; SMN2TDP1TP53CYP3A4 | |
| SCHEMBL28804165 | 0.81 | SMN1; SMN2 (0.39) | ALDH1A1SMN1; SMN2TDP1TP53CYP3A4 | |
| SCHEMBL14977243 | 0.81 | ALDH1A1 (0.46) | ALDH1A1SMN1; SMN2TDP1TP53CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10815186-B2 | Preparation of vegetable oil-based monomers for use in thermosetting resins | WASHINGTON STATE UNIVERSITY (US) | 2020-10-27 | — | — | US | disclosed |
| US-10752803-B2 | 1K high hardness, high impact resistance coating | THE SHERWIN-WILLIAMS COMPANY (US) | 2020-08-25 | — | — | US | disclosed |
| US-20200062688-A1 | PREPARATION OF VEGETABLE OIL-BASED MONOMERS FOR USE IN THERMOSETTING RESINS | WASHINGTON STATE UNIVERSITY | 2020-02-27 | — | — | US | disclosed |
| US-20190085202-A1 | 1K HIGH HARDNESS, HIGH IMPACT RESISTANCE COATING | THE SHERWIN-WILLIAMS COMPANY (US) | 2019-03-21 | — | — | US | disclosed |
| US-20170342296-A1 | 1K 100% SOLIDS DRY-ERASE COATING COMPOSITION | THE SHERWIN-WILLIAMS COMPANY (US) | 2017-11-30 | — | — | US | disclosed |
| US-20170342296-A1 | 1K 100% SOLIDS DRY-ERASE COATING COMPOSITION | THE SHERWIN-WILLIAMS COMPANY (US) | 2017-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200062688-A1 | PREPARATION OF VEGETABLE OIL-BASED MONOMERS FOR USE IN THERMOSETTING RESINS | FASN, REV1, WDR48 | ALDH1A1 3392/4885SMN1; SMN2 1185/4885TDP1 2394/4885 |
| US-10815186-B2 | Preparation of vegetable oil-based monomers for use in thermosetting resins | FASN, REV1, WDR48 | ALDH1A1 3392/4885SMN1; SMN2 1185/4885TDP1 2394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.